Pipeline for creating synthetic images and validation process.
February 21, 2022
New Tool for 3-D Measurement of the Aorta May Identify Fatal Heart Conditions Earlier
February 21, 2022 – Researchers at Michigan Medicine have found a novel method of measuring growth in the body’s…
Read More
Evonik Venture Capital has invested in CircumFix Solutions, a Tennessee-based start-up that has developed a new sternal closure device to improve patient recovery after open chest surgery. The patented orthopedic device, made of a high-performance polymer from Evonik, closes and holds the sternum securely together after surgery. 
February 18, 2022
Evonik invests in U.S. start-up offering medical device to improve patient recovery after open-chest surgery
January 18, 2022 – Evonik Venture Capital has invested in CircumFix Solutions, a Tennessee-based start-up that has…
Read More
Daxor’s Blood Volume (BVA-100) Diagnostic
February 18, 2022
Study Demonstrates Importance and Clinical Utility of Daxor’s Blood Volume (BVA-100) Diagnostic in the Assessment of Heart Failure
February 18, 2022 – Daxor Corporation, the global leader in blood volume measurement technology, has announced new data…
Read More
Front Line Medical Technologies, Inc. today announced the expanded availability and distribution of its COBRA-OS (Control of Bleeding, Resuscitation, Arterial Occlusion System), as U.S. and Canadian hospitals continue to implement the life-saving aortic occlusion device during various surgical and emergency cases.
February 18, 2022
Front Line Medical Technologies Expands Availability of its COBRA-OS
February 18, 2022 – Front Line Medical Technologies, Inc. today announced the expanded availability and distribution of…
Read More
Already used in single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) for adult patients, Rapiscan is now approved for use in stress cardiac magnetic resonance imaging (CMR)
February 18, 2022
GE Healthcare’s Stress Agent Rapiscan Approved for use in Stress Cardiac Magnetic Resonance Imaging
February 18, 2022 — GE Healthcare has announced that it has received approval from the European Medicines Agency (EMA)…
Read More
Clinical Case of the Month
February 17, 2022
Call for Entries!
We are launching something new—a Clinical Case of the Month—and we want you to contribute! Do you have a clinical case…
Read More
Myocarditis (inflammation of the heart muscle) after vaccination is rare, but some cases have been reported after receipt of the Pfizer/BioNTech or Moderna mRNA COVID-19 vaccine.
February 17, 2022
COVID Vax–related Myocarditis May be Milder Than That of Other Causes
February 17, 2022 — While cardiac imaging shows that COVID-19 vaccine–associated myocarditis has a similar pattern as…
Read More
Mytonomy, known for raising the bar in video-based patient-engagement content and platform, is leveraging its capabilities in the cardiology space with its new Cloud for Cardiology.
February 17, 2022
Mytonomy Announces Cardiology Content and Platform
February 17, 2022 – Mytonomy, known for raising the bar in video-based patient-engagement content and platform, is…
Read More
In January, The University of Maryland School of Medicine (UMSOM) and the University of Maryland Medical Center (UMMC) successfully executed a groundbreaking porcine heart transplant procedure in a human. This was the first successful transplant of a genetically modified pig’s heart into a human patient.
By Melinda Taschetta-Millane
February 16, 2022
Pig Heart Transplant Patient Continues to Thrive
In January, The University of Maryland School of Medicine (UMSOM) and the University of Maryland Medical Center (UMMC)…
Read More
Elixir Medical, a developer of innovative, drug-eluting cardiovascular devices, has announced completion of enrollment in the BIOADAPTOR randomized controlled trial (RCT). The BIOADAPTOR RCT is evaluating the DynamX Coronary Bioadaptor System,
February 16, 2022
Elixir Medical Completes Enrollment in Bioadaptor Randomized Controlled Trial of DynamX Coronary Bioadaptor System
February 16, 2022 – Elixir Medical, a developer of innovative, drug-eluting cardiovascular devices, has announced…
Read More
Conavi Medical Inc., a leader of hybrid imaging guidance for common minimally invasive heart procedures, plans to expand the presence of its Novasight Hybrid System in the U.S. market in 2022 under the guidance of its new leadership team.
February 16, 2022
Conavi Medical Plans for Strategic Expansion in U.S. Market
Conavi Medical Inc., a leader of hybrid imaging guidance for common minimally invasive heart procedures, plans to…
Read More
Cardiology is an inherently data-dependent and data-driven practice. Patient medical history records, images, test results, and more go into every diagnosis and treatment decision.
February 16, 2022
Structured Cardiology Reporting in CVIS Platforms Key to Better Patient Care, Outcomes
February 16, 2022 – Cardiology is an inherently data-dependent and data-driven practice. Patient medical history…
Read More
Inari Medical, Inc. has announced that the first patient has been enrolled in PEERLESS, a prospective, randomized controlled trial comparing the outcomes of patients with intermediate-high risk pulmonary embolism (PE) treated with the FlowTriever system versus catheter-directed thrombolysis (CDT).
February 16, 2022
Inari Medical Announces First Patient Enrolled in the PEERLESS Trial
February 16, 2022 – Inari Medical, Inc. has announced that the first patient has been enrolled in PEERLESS, a…
Read More
The Heart Institute at Children’s Hospital Colorado (Children’s Colorado) has performed its 500th pediatric heart transplant, a milestone that only a few centers across the country have reached.
February 16, 2022
500th Heart Transplant Performed at Children’s Hospital Colorado
February 16, 2022 – The Heart Institute at Children’s Hospital Colorado (Children’s Colorado) has performed its 500th…
Read More
A new way of treating arrhythmias, including atrial fibrillation (AF) — the most common heart arrhythmia diagnosis in clinical practice — has debuted at UC San Diego Health. vMap is a non-invasive, computational mapping system that produces a three-dimensional, interactive map of arrhythmia hotspots anywhere in the heart, including all four chambers of the organ, the septal wall and the outflow tracts.
February 16, 2022
Remapping Atrial Fibrillation Treatment
February 16, 2022 – A new way of treating arrhythmias, including atrial fibrillation (AF) — the most common heart…
Read More
Amir Sheikhi, assistant professor of chemical engineering and biomedical engineering, Penn State. Image credit: Penn State College of Engineering
February 16, 2022
Researchers Aim to Improve Stroke Recovery with New Granular Biomaterials
February 16, 2022 – The Centers for Disease Control and Prevention estimate that someone in the United States has a…
Read More
February 16, 2022
'Bionic' Pacemaker Reverses Heart Failure
February 16, 2022 – A revolutionary pacemaker that re-establishes the heart’s naturally irregular beat is set to be…
Read More
Philips Azurion 7 C20
February 16, 2022
Fremont Bank Foundation Donates $750,000 to St. Rose Hospital Foundation to Enhance Its Cardiac Catheterization Laboratory Equipment
February 16, 2022 – Fremont Bank Foundation recently donated $750,000 to its community partner, St. Rose Hospital…
Read More
American Heart Association CEO Nancy Brown issued the following statement in response to the Senate confirmation of Robert M. Califf, M.D., as commissioner of the Food and Drug Administration (FDA)
February 15, 2022
Robert M. Califf, M.D., Confirmed to Lead FDA
February 15, 2022 — American Heart Association CEO Nancy Brown issued the following statement in response to the Senate…
Read More
More than $625,000 in research grants devoted to congenital heart defects (CHD) were awarded today by the American Heart Association, the leading voluntary health organization devoted to a world of longer, healthier lives, and The Children’s Heart Foundation, the nation’s leading organization dedicated to funding CHD research.
February 15, 2022
More than $625,000 Awarded to Better Understand, Identify and Treat Congenital Heart Defects
February 15, 2022 – More than $625,000 in research grants devoted to congenital heart defects (CHD) were awarded today…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now